HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert F Mullins Selected Research

Vitelliform Macular Dystrophy

12/2014Stem cells as tools for studying the genetics of inherited retinal degenerations.
12/2014Transcriptomic analysis across nasal, temporal, and macular regions of human neural retina and RPE/choroid by RNA-Seq.
7/2007Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease.
5/2007Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease.
11/2005Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert F Mullins Research Topics

Disease

28Macular Degeneration (Age-Related Maculopathy)
03/2022 - 07/2005
12Retinal Degeneration
01/2022 - 06/2004
10Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2022 - 09/2005
8Blindness (Hysterical Blindness)
01/2022 - 01/2016
7Retinal Diseases
01/2021 - 02/2011
6Ganglion Cysts (Ganglion)
12/2021 - 01/2007
5Inflammation (Inflammations)
01/2019 - 06/2010
5Vitelliform Macular Dystrophy
12/2014 - 11/2005
4Glaucoma
12/2021 - 01/2012
4Infections
01/2020 - 05/2011
4Burns
11/2017 - 11/2007
3Stargardt Disease
03/2022 - 12/2013
3Open-Angle Glaucoma (Glaucoma, Open Angle)
11/2019 - 01/2012
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2019 - 01/2016
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 01/2017
2Epiretinal Membrane (Epiretinal Membranes)
05/2020 - 02/2019
2Retinal Perforations
05/2020 - 05/2015
2Retinal Detachment (Retinal Detachments)
05/2020 - 02/2019
2Wounds and Injuries (Trauma)
01/2020 - 12/2008
2Vascular Diseases (Vascular Disease)
01/2020 - 11/2019
2Neoplasms (Cancer)
01/2016 - 02/2011
2Eye Diseases (Eye Disease)
02/2012 - 12/2010
2Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl)
07/2007 - 06/2004
1Deafness (Deaf Mutism)
03/2022
1Retinal Dystrophies
03/2022
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
03/2022
1Iron Overload
01/2022
1Common Variable Immunodeficiency
01/2022
1Telangiectasis (Telangiectasia)
12/2021
1Hypertension (High Blood Pressure)
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Usher Syndromes (Usher Syndrome)
10/2020
1Vitreous Hemorrhage
05/2020
1Necrosis
01/2020
1Macular Edema
12/2019
1Fibrosis (Cirrhosis)
02/2019
1Retinoschisis (Retinoschisis, Juvenile)
01/2019
1Genomic Instability
01/2019
1Geographic Atrophy
01/2019
1Enhanced S-Cone Syndrome
01/2019
1Oxyphilic Adenoma (Oncocytoma)
12/2018
1Optic Nerve Diseases (Optic Neuropathy)
12/2018
1renal Oncocytoma
12/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Septic Shock (Toxic Shock Syndrome)
11/2017
1Acute Kidney Injury (Acute Renal Failure)
11/2017
1Leber Congenital Amaurosis
01/2017
1Foreign Bodies (Foreign Body)
11/2016
1Diabetes Mellitus
05/2016
1Diabetic Neuropathies (Diabetic Neuropathy)
05/2016
1Hypersensitivity (Allergy)
01/2016
1North Carolina type 1 retinal Macular dystrophy
01/2016

Drug/Important Bio-Agent (IBA)

35Retinaldehyde (Retinal)IBA
03/2022 - 11/2006
10Proteins (Proteins, Gene)FDA Link
01/2017 - 06/2004
7Complement System Proteins (Complement)IBA
01/2022 - 10/2010
5RNA (Ribonucleic Acid)IBA
01/2021 - 07/2007
4Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2013
4AntibodiesIBA
01/2014 - 12/2010
3Biological ProductsIBA
01/2022 - 01/2012
3Complement Membrane Attack Complex (Membrane Attack Complex)IBA
11/2018 - 11/2014
3Phosphotransferases (Kinase)IBA
01/2017 - 08/2011
3BestrophinsIBA
07/2007 - 11/2005
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2012
2C-Reactive ProteinIBA
11/2018 - 10/2016
2Pharmaceutical PreparationsIBA
11/2016 - 09/2014
2Anti-Bacterial Agents (Antibiotics)IBA
07/2015 - 03/2008
2Glycoproteins (Glycoprotein)IBA
05/2011 - 04/2002
2GlycoconjugatesIBA
07/2007 - 07/2005
1SodiumIBA
03/2022
1Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link
03/2022
1IronIBA
01/2022
1Retinal Pigments (Pigments, Visual)IBA
01/2022
1Complement Factor H (Factor H)IBA
01/2022
1polycaprolactoneIBA
01/2022
1Immunoglobulin A (IgA)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Angiotensin IIIBA
01/2021
1Toll-Like Receptor 2IBA
01/2020
1Fluorescein (Funduscein)FDA LinkGeneric
12/2019
1Amyloid (Amyloid Fibrils)IBA
11/2019
1Bevacizumab (Avastin)FDA Link
02/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1AgglutininsIBA
01/2019
1B-Form DNA (B-DNA)IBA
01/2019
1Phosphopyruvate Hydratase (Enolase)IBA
12/2018
1Endoplasmic Reticulum Chaperone BiPIBA
09/2018
1trabecular meshwork-induced glucocorticoid response proteinIBA
09/2018
1PolymersIBA
01/2017
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
05/2016
1Deoxyribonucleases (DNase)FDA Link
01/2016
1Connexin 43 (Connexin43)IBA
01/2016

Therapy/Procedure

8Therapeutics
12/2021 - 03/2010
5Transplantation
01/2018 - 01/2013
2Vitrectomy
05/2020 - 05/2015
2Length of Stay
07/2009 - 11/2007
1Surgical Amputation (Amputations)
01/2020
1Traction
02/2019
1Renal Replacement Therapy (Therapies, Renal Replacement)
11/2017
1Hemofiltration
11/2017